Physicochemical Properties
| Molecular Formula | C21H24N4O2 |
| Molecular Weight | 364.440864562988 |
| Exact Mass | 364.189 |
| CAS # | 1644156-56-8 |
| PubChem CID | 118430507 |
| Appearance | White to off-white solid powder |
| LogP | 3.7 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 6 |
| Heavy Atom Count | 27 |
| Complexity | 473 |
| Defined Atom Stereocenter Count | 0 |
| SMILES | O(C(C)C)C1C(C(C2C=CC=CC=2)O)=C(C)N(C2=NC=C(C=N2)C2CC2)N=1 |
| InChi Key | BSNKBAPMWCMENP-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C21H24N4O2/c1-13(2)27-20-18(19(26)16-7-5-4-6-8-16)14(3)25(24-20)21-22-11-17(12-23-21)15-9-10-15/h4-8,11-13,15,19,26H,9-10H2,1-3H3 |
| Chemical Name | [1-(5-cyclopropylpyrimidin-2-yl)-5-methyl-3-propan-2-yloxypyrazol-4-yl]-phenylmethanol |
| Synonyms | DHODHIN5; DHODH IN 5 |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| References |
[1]. Original 2-(3-alkoxy-1H-pyrazol-1-yl)pyrimidine derivatives as inhibitors of human dihydroorotate dehydrogenase (DHODH). J Med Chem. 2015 Jan 22;58(2):860-77. |
Solubility Data
| Solubility (In Vitro) | DMSO : ~125 mg/mL (~342.99 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: 6.25 mg/mL (17.15 mM) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution; with sonication. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 62.5 mg/mL clear DMSO stock solution to 900 μL corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.7439 mL | 13.7197 mL | 27.4394 mL | |
| 5 mM | 0.5488 mL | 2.7439 mL | 5.4879 mL | |
| 10 mM | 0.2744 mL | 1.3720 mL | 2.7439 mL |